filmov
tv
Algernon Pharmaceuticals Stroke/DMT Clinical Program
Показать описание
Join Christopher J. Moreau, CEO of Algernon Pharmaceuticals discuss repurposing DMT from its psychedelic effects to a new potential treatment for Stroke. April 2022
0:01:55
0:04:13
0:03:39
0:04:49
0:03:51
0:05:38
0:04:12
0:04:43
0:05:36
0:03:18
0:03:25
0:01:49
0:06:50
0:04:33
0:04:49
0:05:08
0:04:28
0:00:43
0:05:09
0:06:50
0:03:42
0:08:16
0:40:36
0:00:21